FDA approves world’s first cellular therapy for type-1 diabetes

by admin | Jul 10, 2023 | News & Opinions

by Mrigakshi Dixit – Interesting Engineering Named Lantidra, it’s a cellular therapy developed using deceased donor pancreatic cells for the treatment of type 1 diabetes in adults. Therapy suitable for patients with hypoglycemia Type 1 diabetes makes the...

The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma

by admin | Jul 7, 2023 | News & Opinions

By Anne Trafton | MIT News Office Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn’t worked as well for solid tumors. One reason for this lack of success is that the T cells...

Ax-2 Crew Conducted Studies During Mission to Understand Human Physiology in Microgravity

by admin | Jul 6, 2023 | News & Opinions

By Ax-2 Mission Ax-2 Mission Specialist Ali Alqarni uses the Smarting Pro EEG device aboard the ISS to conduct brain studies. During Axiom Mission 2 (Ax-2), the Ax-2 astronauts measured changes in their eyes, blood pressure, blood oxygen, and heart rate levels, as...

Read the June issue of Stem Cells Translational Medicine, now online

by admin | Jul 5, 2023 | News & Opinions

By Stem Cells Translational Medicine READ THE JUNE ISSUE Human Clinical Article Cell-Based Drug Development, Screening, and Toxicology Enabling Technologies for Cell-Based Clinical Translations Manufacturing for Regenerative Medicine and more…. Click Here to...

BlueRock’s neuronal stem cell therapy for Parkinson’s disease is first to show positive results in Phase I clinical study

by admin | Jul 3, 2023 | News & Opinions

By BlueRock Therapeutics Berlin, Germany and Cambridge, M.A., U.S.A., June 28, 2023 – Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly owned independently operated subsidiary of Bayer AG, today announced positive top-line results...